LONDON Reuters Germany's Merck KGaA MRCG

Cheick Kongo and Antonio Rodrigo Nogueira are 6'4", with Junior Dos Santos being somewhere between 6'3" and 6'4". Brock Lesnar is also somewhere around there.I can go on, but I think I have made my point.UFC still has a long way to go in getting their fighter's heights right, and they may never even attempt to correct the "facts" they have right now. Some are minimal errors that can be understood, but Shane Carwin at 6'3"You gotta be kidding me. He stands victorious while all of his opponents are lying on the mat; that's what matters. Meanwhile, Kobe Bryant might be able to play a game without making a single mistake, and Tiger Woods might play a flawless game of golf. Apparently, in a YouTube video, Woods can even walk on water, but in the world MMA, no one is perfect.

No one canbe perfect.Disregarding a few flash knockouts that end in a matter of seconds, every fighter leaves the Octagon or ring in a bruised or battered state.We will cheer for our fighters, regardless of whether they are 5'5" or 6'5". As long as they bring a good fight, we will pay, and we will watch.. LONDON (Reuters) - Germany's Merck KGaA (MRCG.DE) could unlock substantial value by selling its consumer health business to a larger company, with France's Sanofi-Aventis (SASY.PA) an obvious buyer, according to a leading analyst. Deals Inflows OutflowsUBS analyst Gbola Amusa values the over-the-counter (OTC) drugs unit at 2.1 billion euros ($2.8 billion), or 4.5 times sales, reflecting fierce competition for assets in a defensive sector with steady cash flows and no patent expiry worries."We think it reasonable for Merck to sell the business, and Sanofi-Aventis would be a logical buyer," he said.Other established players like GlaxoSmithKline (GSK.L) should not be ruled out, but Amusa said the Merck business, whose products include the Seven Seas brand of supplements, made most sense as a target for Sanofi.The French group is widely expected to embark on a strategy of acquisitions to diversify operations under new Chief Executive Chris Viehbacher, who took over last month.It recently bought Symbion to expand its OTC presence in Australia and has a 1,150 crowns per share bid outstanding for Czech generics manufacturer Zentiva.The $100 billion-a-year global OTC healthcare market has seen a wave of consolidation recently, with big companies like Johnson & Johnson (JNJ.N), Novartis (NOVN.VX), Reckitt Benckiser (RB.L) and Glaxo all acquiring assets."There are tremendous economies of scale in the OTC world and Merck is hampered because it's sub-efficient scale and so focused in Europe," Amusa said."The families (that control Merck) have been holding on to it, likely because there is some stability in the cash flows of this business. But it's worth more to other companies."Amusa and colleagues at UBS said in a research note the consumer health market should grow by an average 5 percent a year over 2007-12 twice as fast as the European prescription drug market, which faces loss of patent protection on many key products.Merck spokesman Gangolf Schrimpf declined to comment specifically on the UBS report but reiterated previous statements from management that Merck planned to hold on to its four divisions and wanted to strengthen consumer healthcare.UBS, however, noted that Merck made similar comments about retaining generic drugs before selling that business in 2007.At Merck's current 1.9 times 2009 revenue multiple, the Consumer Health Care business is worth less than 900 million euros, implying 1.2 billion euros upside from a sale, UBS said. After taking an extended break from writing about Raider football, I've decided to come back because there is something that has struck me as somewhat urgent.

Week after week, I'd leave the Coliseum or peel myself away from the television with anger, despair, helplessness, impotence, and rage going through my head. My first instinct was to scream, cuss, and just destroy things in my house.Why Well, when you've been watching Raider football for well over 25 years, and when you've been overly optimistic year in and year out, those types of feelings tend to take hold. My solution Take some of what I learned at San Diego State University (Morrison and Schilens were my classmates!), and just go off on people that way.No, JaMarcus Russell isn't going to read it. Heck, how could I expect him to if he doesn't even read that playbook And no, Mr Davis isn't going to read this. Still, it was a way to get over the frustration of what is now Raider football.Now, on to the title of the article. We've all seen the resurgence of the Tennesee Titans over the last five weeks. After starting the season 0-6, they've roared back to life with five straight wins.